June 18, 2008 – MEDRAD gained FDA 510(k) clearance for a new Fluorodeoxyglucose (FDG) infusion system for positron emission tomography/computed tomography (PET/CT) imaging procedures, reportedly the first infusion system available in the U.S. to automate the FDG delivery process.
The new PET infusion system, Intego, reportedly enables the healthcare provider to easily administer FDG at any time throughout the day and enhances the clinician's ability to deliver FDG with precision, flexibility and safety.